Search Results - "Nicolò, Massimo"

Refine Results
  1. 1

    Faricimab: an investigational agent targeting the Tie-2/angiopoietin pathway and VEGF-A for the treatment of retinal diseases by Nicolò, Massimo, Ferro Desideri, Lorenzo, Vagge, Aldo, Traverso, Carlo Enrico

    Published in Expert opinion on investigational drugs (04-03-2021)
    “…Intravitreal antivascular endothelial growth factor (VEGF) drugs represent the first-line treatment option for wet age-related macular degeneration (w-AMD) and…”
    Get more information
    Journal Article
  2. 2

    Abicipar pegol: an investigational anti-VEGF agent for the treatment of wet age-related macular degeneration by Ferro Desideri, Lorenzo, Traverso, Carlo Enrico, Nicolò, Massimo

    Published in Expert opinion on investigational drugs (02-07-2020)
    “…Several approaches have been investigated for the management of wet age-related macular degeneration (w-AMD); however, the first-line treatment option for…”
    Get more information
    Journal Article
  3. 3

    Choroidal Vascular Flow Area in Central Serous Chorioretinopathy Using Swept-Source Optical Coherence Tomography Angiography by Nicolò, Massimo, Rosa, Raffaella, Musetti, Donatella, Musolino, Maria, Saccheggiani, Michela, Traverso, Carlo Enrico

    “…To report the choroidal vascular flow area in eyes with central serous chorioretinopathy (CSC) compared with healthy subjects and unaffected fellow eyes using…”
    Get full text
    Journal Article
  4. 4

    Evaluation of choroidal thickness and choroidal vascular blood flow in patients with thyroid-associated orbitopathy (TAO) using SD-OCT and Angio-OCT by Del Noce, Chiara, Vagge, Aldo, Nicolò, Massimo, Traverso, Carlo Enrico

    “…Purpose The aim of this study was to evaluate changes in choroidal thickness and in choroidal vascular blood flow in patients with thyroid-associated…”
    Get full text
    Journal Article
  5. 5

    The emerging role of the Angiopoietin-Tie pathway as therapeutic target for treating retinal diseases by Ferro Desideri, Lorenzo, Traverso, Carlo Enrico, Nicolò, Massimo

    Published in Expert opinion on therapeutic targets (01-02-2022)
    “…Several approaches have been investigated for treating wet age-related macular degeneration (w-AMD), diabetic macular edema (DME) and retinal vein occlusions…”
    Get more information
    Journal Article
  6. 6

    Vigorous Physical Activity as a Risk Factor for Central Serous Chorioretinopathy by Piccolino, Felice Cardillo, Fruttini, Daniela, Eandi, Chiara, Nicolò, Massimo, Mariotti, Cesare, Tito, Silvia, Lupidi, Marco

    Published in American journal of ophthalmology (01-12-2022)
    “…To evaluate whether frequent vigorous physical activity (PA) is significantly associated with active central serous chorioretinopathy (CSCR) and may represent…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10

    Faricimab for the Treatment of Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration by Ferro Desideri, Lorenzo, Traverso, Carlo Enrico, Nicolò, Massimo, Munk, Marion R

    Published in Pharmaceutics (05-05-2023)
    “…Nowadays; intravitreal anti-vascular endothelial growth factor (VEGF) drugs are considered the first-line therapeutic strategy for treating macular exudative…”
    Get full text
    Journal Article
  11. 11

    Hydroxychloroquine and chloroquine retinal safety concerns during COVID-19 outbreak by Nicolò, Massimo, Ferro Desideri, Lorenzo, Bassetti, Matteo, Traverso, Carlo Enrico

    Published in International ophthalmology (01-02-2021)
    “…Purpose The current coronavirus disease 2019 (COVID-19) has been declared by the World Health Organization a global pandemic. Chloroquine (CQ) and…”
    Get full text
    Journal Article
  12. 12

    Choroidal Vascular Reactivity in Central Serous Chorioretinopathy by Cardillo Piccolino, Felice, Lupidi, Marco, Cagini, Carlo, Fruttini, Daniela, Nicolò, Massimo, Eandi, Chiara Maria, Tito, Silvia

    “…To investigate by optical coherence tomography angiography (OCT-A) the choroidal vascular response to experimentally increased blood pressure in patients with…”
    Get full text
    Journal Article
  13. 13

    Clinical efficacy and safety of ranibizumab in the treatment of wet age-related macular degeneration by Ferro Desideri, Lorenzo, Barra, Fabio, Ferrero, Simone, Traverso, Carlo Enrico, Nicolò, Massimo

    Published in Expert opinion on biological therapy (03-08-2019)
    “…: Although several approaches have been studied for treating wet age-related macular degeneration (w-AMD), currently, the most effective strategy in the…”
    Get more information
    Journal Article
  14. 14

    Current Pharmacological Treatment Options for Central Serous Chorioretinopathy: A Review by Nicolò, Massimo, Ferro Desideri, Lorenzo, Vagge, Aldo, Traverso, Carlo Enrico

    Published in Pharmaceuticals (Basel, Switzerland) (23-09-2020)
    “…Central serous chorioretinopathy (CSC) is a common cause of visual impairment in patients generally aged 20 to 60 and it is characterized by acute or chronic…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Concerns on ranibizumab and zoledronic acid safety for experimentally treating women with endometriosis by Barra, Fabio, Ferro Desideri, Lorenzo, Gustavino, Claudio, Ferrero, Simone, Traverso, Carlo Enrico, Nicolò, Massimo

    Published in Archives of gynecology and obstetrics (01-08-2022)
    “…Correspondence to the original research entitled “Effects of ranibizumab and zoledronic acid on endometriosis in a rat model” published by Ozdemir et al…”
    Get full text
    Journal Article
  17. 17

    Chronic Neovascular Central Serous Chorioretinopathy: A Stress/Rest Optical Coherence Tomography Angiography Study by Lupidi, Marco, Fruttini, Daniela, Eandi, Chiara Maria, Nicolò, Massimo, Cabral, Diogo, Tito, Silvia, Cagini, Carlo, Cardillo Piccolino, Felice

    Published in American journal of ophthalmology (01-03-2020)
    “…To compare optical coherence tomography-angiography (OCT-A) performed during physical exercise (stress OCT-A) to the basal examination (rest OCT-A) in the…”
    Get full text
    Journal Article
  18. 18

    Bilateral choroidal detachment and myopic shift after acetazolamide intake for laser capsulotomy by Musetti, Donatella, Nicolò, Massimo, Bagnis, Alessandro, Cutolo, Carlo Alberto, Traverso, Carlo Enrico

    Published in European journal of ophthalmology (01-01-2022)
    “…Introduction: To report a case of bilateral choroidal effusion after laser capsulotomy. Case description: A healthy 85 years old white woman was referred to…”
    Get full text
    Journal Article
  19. 19

    Prechoroidal Cleft Regression After Switch to Intravitreal Brolucizumab by Forte, Paolo, Ferro Desideri, Lorenzo, Manocchio, Riccardo, Corazza, Paolo, Traverso, Carlo Enrico, Nicolò, Massimo

    Published in European journal of ophthalmology (01-01-2024)
    “…Introduction Prechoroidal cleft has been described as a negative prognostic biomarker in patients affected with neovascular age related macular degeneration…”
    Get full text
    Journal Article
  20. 20

    Autonomous artificial intelligence versus teleophthalmology for diabetic retinopathy by Musetti, Donatella, Cutolo, Carlo Alberto, Bonetto, Monica, Giacomini, Mauro, Maggi, Davide, Viviani, Giorgio Luciano, Gandin, Ilaria, Traverso, Carlo Enrico, Nicolò, Massimo

    Published in European journal of ophthalmology (24-04-2024)
    “…Purpose: To assess the role of artificial intelligence (AI) based automated software for detection of Diabetic Retinopathy (DR) compared with the evaluation of…”
    Get full text
    Journal Article